Jason Zhang receives V Foundation grant to uncover how glioblastoma evades treatment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Jason Zhang, an assistant professor of bioengineering in the UCLA Samueli School of Engineering and a member of the UCLA Health Jonsson Comprehensive Cancer Center, has received an $800,000 grant from the V Foundation for Cancer Research to investigate how glioblastoma cells become resistant to targeted treatments. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Throughout my career as a physician and scientist, I’ve seen ideas once considered impossible become breakthroughs that save lives. They happened because talented scientists had the resources, institutions, and sustained support to pursue ambitious ideas. Most importantly, they knew patients could not afford to wait. 
The International Myeloma Society, in partnership with the Paula and Rodger Riney Foundation, is accepting applications for more than $3 million in research funding through its 2027 Translational Research and Career Development awards. The awards support research to improve the prevention, early detection, diagnosis, and treatment of multiple myeloma and related plasma cell disorders, while developing the next generation of researchers in the field.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login